title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner",20220712T130420,https://www.benzinga.com/general/biotech/22/07/28031430/the-daily-biotech-pulse-gsk-to-supply-50m-flu-vaccine-doses-to-us-fda-lifts-hold-on-greenwichs-ca,GSK,0.172097,Neutral,0.076079
"Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More",20241211T145500,https://www.zacks.com/stock/news/2382213/biotech-stock-roundup-bioa-down-on-study-update-qure-crdf-gain-on-study-data-more,GSK,0.080188,Neutral,0.060458
Global Gastroparesis Treatment Market is Expected to Grow Revenue up to USD 11.09 Billion By 2030 with a Growing CAGR of 3.3% | Infinium Global Research,20231027T093000,https://www.prnewswire.com/news-releases/global-gastroparesis-treatment-market-is-expected-to-grow-revenue-up-to-usd-11-09-billion-by-2030-with-a-growing-cagr-of-3-3--infinium-global-research-301969986.html,GSK,0.041682,Neutral,-0.084698
Gilead  ( GILD )  Magrolimab Studies' Partial Clinical Hold Removed,20220412T152000,https://www.zacks.com/stock/news/1897942/gilead-gild-magrolimab-studies-partial-clinical-hold-removed,GSK,0.130713,Neutral,0.036482
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Science Applications Intl  ( NASDAQ:SAIC ) ,20240603T175653,https://www.benzinga.com/news/24/06/39143340/why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-i,GSK,0.074926,Neutral,-0.096246
GSK: 3 A-Rated Medical Stocks to Watch and Buy,20240117T193121,https://stocknews.com/news/gsk-nhc-mdxg-3-a-rated-medical-stocks-to-watch-and-buy/,GSK,0.234968,Somewhat-Bullish,0.248639
"Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves - Verona Pharma  ( NASDAQ:VRNA ) ",20231229T182429,https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36429939/verona-pharmas-promising-copd-treatment-puts-it-in-gsks-acquisition-crosshairs-anal,GSK,0.392948,Somewhat-Bullish,0.249627
Adaptimmune  ( ADAP )  Down on End of Collaboration With Roche,20240415T181200,https://www.zacks.com/stock/news/2255611/adaptimmune-adap-down-on-end-of-collaboration-with-roche,GSK,0.267804,Somewhat-Bullish,0.150458
